Discovering the role of big data in driving early infectious disease detection

Discovering the role of big data in driving early infectious disease detection

8-11-2018 by Marike van Beuge Since the introduction of antimicrobials, starting with penicillin in the 20th century, these life-saving drugs have revolutionised our society and economy. Previously deadly diseases have become routine ailments, requiring little more than a brief treatment. However, due to a range of factors, including rising antimicrobial resistance, infectious disease threats are (re-)emerging, … Continue Reading

Catalyze wins FD Gazellen award

Catalyze wins FD Gazellen award

Earlier this year Catalyze opened new offices in Denmark and Switzerland, becoming a truly international company with its headquarter in Amsterdam. Now, Catalyze receives a FD Gazellen award, meaning that it is one of the fastest growing companies in the Netherlands. “We are very proud to receive this award. It is a great acknowledgement for… Continue Reading

Future topics for IMI call 17 published

Future topics for IMI call 17 published

New future topics draft texts for IMI call 17 have been published. Although these topics are not final yet, it is at this stage unlikely that they will change. We have summarised the most important information below. Optimising future obesity treatment The aim of this topic is to identify pathophysiologically and clinically meaningful subgroups of… Continue Reading

Khondrion – in search of treatment for mitochondrial diseases

Khondrion – in search of treatment for mitochondrial diseases

11-10-2018 Interview with Jan Smeitink, CEO of Khondrion Eight years ago, Jan Smeitink looked at himself in the mirror and decided he is going to change the world. Today, Jan is the Chief Executive Officer of Khondrion and is starting Phase 2b clinical trials for his revolutionary drug, KH176 – which might well become the… Continue Reading

Updates to Dutch funding programmes

Updates to Dutch funding programmes

10-10-2018 There have been some recent updates to the Dutch funding programmes. Below we highlight the most important information: OP Oost OP Oost published a new update on the available budget on their website. There’s still budget available for all tenders and topics in both provinces (Overijssel and Gelderland). Only for the General Innovation –… Continue Reading

When research projects don’t go as planned: making amendments

When research projects don’t go as planned: making amendments

28-9-2018 by Tim van Beelen European research and innovation programmes are important contributors to the scientific excellence of European Universities and to the innovation capacity of Small-and-Medium Enterprises.  European science thrives, supported by these grants. Making applications is, of course, extremely competitive. Once successfully awarded, the complexities of a grant will need to be effectively… Continue Reading

Event: Non-dilutive funds for Life Sciences Innovations

Event: Non-dilutive funds for Life Sciences Innovations

On the 7th of November 2018, we are co-hosting an event at the Switzerland Innovation Park Basel Area AG. This event is co-hosted by Catalyze and Euresearch, we will talk about funding opportunities for Swiss startups and researchers. Non-dilutive funds for Life Sciences Innovations 7 November 2018, 16:45-18:00 Switzerland Innovation Park Basel Area AG, Gewerbestrasse 24,… Continue Reading

Is your SME ready for the fast track?

Is your SME ready for the fast track?

26-9-2018 by Leanne Schmitz You have invested in development of a breakthrough technology, product or service. You are almost ready to shake up the market, but you need a final push. With funding up to €3M, the Fast Track to Innovation (FTI) program is an attractive opportunity to support close-to-market activities of breakthrough innovations. However,… Continue Reading

H2020-funded clinical trials: avoiding the pitfalls and ensuring success

H2020-funded clinical trials: avoiding the pitfalls and ensuring success

24-9-2018 by Olav Veldhuizen European research and innovation programmes have been extremely important for clinical trials over many years and continue to be a vital source of funding for therapy development under Horizon2020. However, navigating successful delivery of such funded projects can be challenging. Significant support for clinical trial projects is available through H2020 Challenge… Continue Reading

All services

In our approach we combine both non-dilutive and dilutive funding. Let’s start working on your project together now!

 

Welcome at Catalyze!

Catalyze uses cookies in order to improve your user experience. By using this website you agree to our policy.

Go back or